Skip to main content

Xylem Reports Second Quarter 2026 Results

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Second-Quarter Highlights

  • Orders of $3.1 billion, up 42% on a reported basis and 41% organically
  • Revenue of $2.3 billion, up 2% on a reported basis and 1% organically
  • Earnings per share of $1.11, up 19%; $1.46 on an adjusted basis, up 16%

Xylem Inc. (NYSE: XYL), a leading global water solutions company dedicated to solving the world’s most challenging water issues, today reported second-quarter 2026 results. The Company delivered total revenue of $2.3 billion, on strong execution. Second-quarter earnings per share were up 19 percent on a reported basis and 16 percent on an adjusted basis.

“The demand drivers behind our business continue to strengthen,” said Matthew Pine, Xylem’s CEO. “Water is becoming increasingly strategic for both utilities and industrial customers. We’ve spent the past several years positioning Xylem for this. Now we’re seeing that strategy create new opportunities and strengthen our competitive position. With a resilient municipal foundation, increasing exposure to attractive industrial markets and a more focused portfolio, we believe Xylem is well positioned for long-term growth and profitability.”

“The opportunities we see today extend well beyond any single end market,” Pine continued. “The growth of AI infrastructure is increasing the strategic importance of water across a broader industrial ecosystem from semiconductors and power generation to mining and other critical industries. At the same time, we are seeing increasing demand across sectors such as food and beverage and life sciences, where water quality, reliability and operational performance are essential. These trends are broadening our opportunity set and reinforcing our confidence in the durability of our long-term strategy.”

Net income attributable to Xylem for the quarter was $263 million, or $1.11 per share. Net income margin increased 150 basis points to 11.3 percent. These results are driven by strong operational performance and lower restructuring and realignment costs, partially offset by increased income tax expense and loss on sale of businesses. Adjusted net income attributable to Xylem was $345 million, or $1.46 per share, which excludes purchase accounting intangible amortization, the loss on sale of businesses, restructuring and realignment costs, and special charges.

Second-quarter adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin was 23.3 percent, reflecting a year-over-year increase of 150 basis points. Productivity savings, strong price realization and mix drove the margin expansion, exceeding the impact of inflation and lower volumes.

Outlook

Xylem now forecasts full-year 2026 revenue of approximately $9.2 billion, up approximately 2 percent on a reported basis, versus 2 to 3 percent previously guided, and up approximately 2 to 3 percent on an organic basis, versus 2 to 4 percent previously guided.

Full-year 2026 adjusted EBITDA margin is expected to be approximately 23.1 to 23.5 percent, an increase of 90 to 130 basis points from Xylem’s 2025 adjusted results. This results in full-year adjusted earnings per share of $5.55 to $5.70, up from the previous guidance range of $5.35 to $5.60. Full-year free cash flow margin is still expected to be approximately 10.2 to 11.0 percent.

Further 2026 planning assumptions are included in Xylem’s second-quarter 2026 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Supplemental information on Xylem’s Second-quarter earnings, as well as definitions of and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a Fortune 500 global water solutions company that empowers customers and communities to build a more water-secure world. Our 22,000 employees delivered revenue of $9 billion in 2025, optimizing water and resource management with innovation and expertise. Join us at www.xylem.com and Let’s Solve Water.

Xylem uses our Investor Relations website, www.xylem.com/en-us/investors, as a means of disclosing information which may be of interest or material to our investors and for complying with disclosure obligations under Regulation FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings, public conference calls, webcasts, and social media.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “forecast,” “likely,” “believe,” “target,” “goal,” “objective,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending, interest rates, availability of funding for our customers, inflation and governments’ related monetary policy in response, and the strength of the real estate markets, on economic activity and our operations; geopolitical matters, including nationalism, protectionism and anti-global sentiment, volatility involving the U.S. and other governments, ongoing, escalation or outbreak of international conflicts, and regulatory, trade protection, economic and other risks associated with our global sales and operations; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, labor shortages, trade agreements, tariffs, and other trade protection measures, and other factors; demand for our products, disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents, data breaches, or other disruptions of information technology systems on which we or our customers rely, or involving our connected products and services; lack of availability or delays in receiving parts and raw materials from our supply chain, including semiconductors or other key components; operational disruptions at our facilities or that of third parties upon which we rely; safe and compliant treatment and handling of water, wastewater and hazardous materials; failure to successfully execute large projects, including as respects performance guarantees and customers’ budgets, timelines and safety requirements; our ability to retain, compete for and attract leadership, other key talent and labor; defects, security, warranty and liability claims, and recalls related to our products; uncertainty around productivity, simplification, restructuring and realignment actions and related costs and savings; our ability to execute strategic investments for growth, including acquisitions and divestitures; availability, regulation or interference with radio spectrum used by certain of our products; volatility in served markets or impacts on our business and operations due to weather conditions, volatile weather events, or changing climate patterns; risks related to our sustainability efforts and related disclosures; fluctuations in foreign currency exchange rates; difficulty predicting our financial results; risk of future impairments to goodwill and other intangible assets; changes in our effective tax rates or tax expenses; failure to comply with, or changes in, laws or regulations, pertaining to our business conduct, operations, products and services, including anti-corruption, artificial intelligence, data privacy and security, trade, competition, the environment, and health and safety; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; matters related to intellectual property infringement or expiration of rights; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).

Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors, to our business, operating results, financial condition, outlook, or strategy, to our impacts on sustainability matters or other parties, or are required to be disclosed in our filings with the SEC or other regulatory authorities, and are not intended to create legal rights or obligations. In addition, historical, current, and forward-looking social, environmental and sustainability-related statements may be based on: standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future.

All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)

(in millions, except per share data)

 

Three Months

 

Six Months

For the periods ended June 30,

2026

 

2025

 

2026

 

2025

Revenue from products

$

1,953

 

 

$

1,911

 

 

$

3,710

 

 

$

3,620

 

Revenue from services

 

383

 

 

 

390

 

 

 

751

 

 

 

750

 

Revenue

 

2,336

 

 

 

2,301

 

 

 

4,461

 

 

 

4,370

 

Cost of revenue from products

 

1,093

 

 

 

1,129

 

 

 

2,150

 

 

 

2,170

 

Cost of revenue from services

 

280

 

 

 

280

 

 

 

545

 

 

 

540

 

Cost of revenue

 

1,373

 

 

 

1,409

 

 

 

2,695

 

 

 

2,710

 

Gross profit

 

963

 

 

 

892

 

 

 

1,766

 

 

 

1,660

 

Selling, general and administrative expenses

 

503

 

 

 

503

 

 

 

975

 

 

 

963

 

Research and development expenses

 

59

 

 

 

58

 

 

 

115

 

 

 

114

 

Restructuring and asset impairment charges

 

11

 

 

 

26

 

 

 

42

 

 

 

47

 

Operating income

 

390

 

 

 

305

 

 

 

634

 

 

 

536

 

Interest expense

 

(7

)

 

 

(9

)

 

 

(11

)

 

 

(17

)

Other non-operating (expense)/income, net

 

(3

)

 

 

3

 

 

 

(3

)

 

 

7

 

Loss on sale of businesses

 

(16

)

 

 

 

 

 

(12

)

 

 

(10

)

Income before taxes

 

364

 

 

 

299

 

 

 

608

 

 

 

516

 

Income tax expense

 

(103

)

 

 

(75

)

 

 

(158

)

 

 

(125

)

Net income

$

261

 

 

$

224

 

 

$

450

 

 

$

391

 

Net loss attributable to non-controlling interests

 

2

 

 

 

2

 

 

 

6

 

 

 

4

 

Net income attributable to Xylem

$

263

 

 

$

226

 

 

$

456

 

 

$

395

 

Earnings per share:

 

 

 

 

 

 

 

Basic

$

1.11

 

 

$

0.93

 

 

$

1.90

 

 

$

1.62

 

Diluted

$

1.11

 

 

$

0.93

 

 

$

1.90

 

 

$

1.62

 

Weighted average number of shares:

 

 

 

 

 

 

 

Basic

 

236.3

 

 

 

243.4

 

 

 

239.5

 

 

 

243.3

 

Diluted

 

236.6

 

 

 

243.9

 

 

 

240.0

 

 

 

243.8

 

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions)

 

June 30,
2026

 

December 31,
2025

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

1,276

 

 

$

1,479

 

Receivables, less allowances for discounts, returns and credit losses of $54 and $68 in 2026 and 2025, respectively

 

1,875

 

 

 

1,759

 

Inventories

 

1,016

 

 

 

983

 

Prepaid and other current assets

 

219

 

 

 

244

 

Assets held for sale

 

8

 

 

 

176

 

Total current assets

 

4,394

 

 

 

4,641

 

Property, plant and equipment, net

 

1,167

 

 

 

1,159

 

Goodwill

 

8,256

 

 

 

8,332

 

Other intangible assets, net

 

2,150

 

 

 

2,272

 

Other non-current assets

 

1,375

 

 

 

1,230

 

Total assets

$

17,342

 

 

$

17,634

 

LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND STOCKHOLDERS’ EQUITY

Current liabilities:

 

 

 

Accounts payable

$

1,013

 

 

$

1,013

 

Accrued and other current liabilities

 

1,180

 

 

 

1,237

 

Short-term borrowings and current maturities of long-term debt

 

531

 

 

 

534

 

Liabilities held for sale

 

 

 

 

72

 

Total current liabilities

 

2,724

 

 

 

2,856

 

Long-term debt

 

2,395

 

 

 

1,408

 

Accrued post-retirement benefit obligations

 

301

 

 

 

317

 

Deferred income tax liabilities

 

446

 

 

 

405

 

Other non-current accrued liabilities

 

810

 

 

 

899

 

Total liabilities

 

6,676

 

 

 

5,885

 

Redeemable non-controlling interest

 

242

 

 

 

258

 

Stockholders’ equity:

 

 

 

Common stock – par value $0.01 per share:

 

 

 

Authorized 750.0 shares, issued 260.3 shares and 259.9 shares in 2026 and 2025, respectively

 

3

 

 

 

3

 

Capital in excess of par value

 

8,787

 

 

 

8,759

 

Retained earnings

 

3,956

 

 

 

3,706

 

Treasury stock – at cost 26.8 shares and 16.3 shares in 2026 and 2025, respectively

 

(2,023

)

 

 

(768

)

Accumulated other comprehensive loss

 

(302

)

 

 

(220

)

Total stockholders’ equity

 

10,421

 

 

 

11,480

 

Non-controlling interests

 

3

 

 

 

11

 

Total equity

 

10,424

 

 

 

11,491

 

Total liabilities, redeemable non-controlling interest, and stockholders’ equity

$

17,342

 

 

$

17,634

 

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in millions)

For the six months ended June 30,

2026

 

2025

Operating Activities

 

 

 

Net income

$

450

 

 

$

395

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Depreciation

 

130

 

 

 

137

 

Amortization

 

150

 

 

 

153

 

Share-based compensation

 

25

 

 

 

25

 

Restructuring and asset impairment charges

 

42

 

 

 

47

 

Loss from sale of businesses

 

12

 

 

 

10

 

Other, net

 

(27

)

 

 

6

 

Payments for restructuring

 

(49

)

 

 

(36

)

Changes in assets and liabilities (net of acquisitions):

 

 

 

Changes in receivables

 

(142

)

 

 

(103

)

Changes in inventories

 

(41

)

 

 

(27

)

Changes in accrued expenses

 

(13

)

 

 

(64

)

Changes in accrued and deferred taxes

 

1

 

 

 

(50

)

Changes in long term receivables

 

(104

)

 

 

(70

)

Other, net

 

(36

)

 

 

(85

)

Net Cash – Operating activities

 

398

 

 

 

338

 

Investing Activities

 

 

 

Capital expenditures

 

(179

)

 

 

(169

)

Acquisitions of businesses, net of cash acquired

 

(1

)

 

 

(7

)

Proceeds from sale of businesses, net of cash disposed

 

59

 

 

 

50

 

Proceeds from the sale of property, plant and equipment

 

11

 

 

 

5

 

Cash paid for investments

 

(3

)

 

 

(3

)

Cash paid for asset acquisition

 

(2

)

 

 

(37

)

Cash received from cross-currency swaps

 

17

 

 

 

21

 

Net Cash – Investing activities

 

(98

)

 

 

(140

)

Financing Activities

 

 

 

Short-term debt issued, net

 

 

 

 

4

 

Long-term debt issued, net

 

990

 

 

 

 

Long-term debt repaid

 

(6

)

 

 

(28

)

Repurchase of common stock

 

(1,243

)

 

 

(13

)

Proceeds from exercise of employee stock options

 

2

 

 

 

8

 

Dividends paid

 

(207

)

 

 

(196

)

Other, net

 

(20

)

 

 

(19

)

Net Cash – Financing activities

 

(484

)

 

 

(244

)

Effect of exchange rate changes on cash

 

(31

)

 

 

84

 

Increase in cash classified within assets held for sale

 

 

 

 

11

 

Decrease in cash classified within assets held for sale

 

12

 

 

 

 

Changes in cash classified within assets held for sale

 

12

 

 

 

11

 

Net change in cash and cash equivalents

 

(203

)

 

 

49

 

Cash and cash equivalents at beginning of year

 

1,479

 

 

 

1,121

 

Cash and cash equivalents at end of period

$

1,276

 

 

$

1,170

 

Supplemental disclosure of cash flow information:

 

 

 

Cash paid during the period for:

 

 

 

Interest

$

29

 

 

$

32

 

Income taxes (net of refunds received)

$

157

 

 

$

175

 

Xylem Inc. Non-GAAP Measures
 
Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures that we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.
 
“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
 
“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and "Adjusted Segment EBITDA" reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.
 
"Adjusted EBITDA Margin" and "Adjusted Segment EBITDA Margin" defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.
 
"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income attributable to Xylem and earnings per share attributable to Xylem, adjusted to exclude restructuring and realignment costs, amortization of acquired intangible assets, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.
 
"Adjusted Operating Margin" and "Adjusted Segment Operating Margin" defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.
 
“Free Cash Flow” defined as net cash from operating activities, less capital expenditures, as reported in the Statement of Cash Flows. Our definition of free cash flow does not consider certain non-discretionary cash payments, such as debt.
 
"Free Cash Flow Margin" defined as free cash flow, adjusted (as applicable) for significant cash paid or received for non-operational tax, acquisition or divestiture activities; divided by revenue.
 
“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
 
“Special charges" defined as non-recurring costs incurred by the Company, such as those related to acquisitions and integrations, divestitures non-cash impairment charges and other special charges. In 2026, these charges include reductions of expense related to the refunds of certain tariffs previously imposed under the International, Emergency Economic Powers Act ("IEEPA").
 
“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic Orders ($ Millions)
   

(As Reported)

 

(As Adjusted - Organic)

 

 

(A)

 

(B)

 

 

 

 

 

(C)

 

(D)

 

(E)

 

(F) = B+C+D+E

 

(G) = F/(A-D)

 

 

 

 

Change

 

% Change

 

 

 

Acquisitions

 

Divestitures

 

 

 

Change

 

% Change

Orders

 

Orders

 

2026 v. 2025

 

2026 v. 2025

 

Book-to-Bill

 

 

 

FX Impact

 

Adj. 2026 v. 2025

 

Adj. 2026 v. 2025

2026

2025

Six Months Ended June 30
Xylem Inc.

5,314

4,332

982

 

23

%

119

%

(27

)

28

(111

)

872

 

20

%

Water Infrastructure

1,344

1,298

46

 

4

%

105

%

(21

)

8

(45

)

(12

)

(1

%)

Applied Water

1,050

974

76

 

8

%

111

%

-

 

-

(20

)

56

 

6

%

Measurement and Control Solutions

905

839

66

 

8

%

89

%

-

 

20

(14

)

72

 

9

%

Water Solutions and Services

2,015

1,221

794

 

65

%

167

%

(6

)

-

(32

)

756

 

62

%

 
Quarter Ended June 30
Xylem Inc.

3,086

2,174

912

 

42

%

132

%

(15

)

23

(41

)

879

 

41

%

Water Infrastructure

669

672

(3

)

(0

%)

98

%

(13

)

3

(13

)

(26

)

(4

%)

Applied Water

538

488

50

 

10

%

107

%

-

 

-

(5

)

45

 

9

%

Measurement and Control Solutions

430

437

(7

)

(2

%)

85

%

-

 

20

(3

)

10

 

2

%

Water Solutions and Services

1,449

577

872

 

151

%

225

%

(2

)

-

(20

)

850

 

147

%

 
Quarter Ended March 31
Xylem Inc.

2,228

2,158

70

 

3

%

105

%

(12

)

5

(70

)

(7

)

(0

%)

Water Infrastructure

675

626

49

 

8

%

112

%

(8

)

5

(32

)

14

 

2

%

Applied Water

512

486

26

 

5

%

114

%

-

 

-

(15

)

11

 

2

%

Measurement and Control Solutions

475

402

73

 

18

%

94

%

-

 

-

(11

)

62

 

15

%

Water Solutions and Services

566

644

(78

)

(12

%)

100

%

(4

)

-

(12

)

(94

)

(15

%)

Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic Revenue ($ Millions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(As Reported - GAAP)

 

(As Adjusted - Organic)

 

 

(A)

 

(B)

 

 

 

(C)

 

(D)

 

(E)

 

(F) = B+C+D+E

 

(G) = F/(A-D)

 

 

 

 

Change

 

% Change

 

Acquisitions

 

Divestitures

 

 

 

Change

 

% Change

Revenue

 

Revenue

 

2026 v. 2025

 

2026 v. 2025

 

 

 

FX Impact

 

Adj. 2026 v. 2025

 

Adj. 2026 v. 2025

2026

 

2025

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended June 30
Xylem Inc.

4,461

4,370

91

 

2

%

(12

)

36

(94

)

21

 

0

%

Water Infrastructure

1,286

1,231

55

 

4

%

(7

)

7

(43

)

12

 

1

%

Applied Water

949

918

31

 

3

%

-

 

-

(19

)

12

 

1

%

Measurement and Control Solutions

1,016

1,030

(14

)

(1

%)

-

 

29

(15

)

-

 

0

%

Water Solutions and Services

1,210

1,191

19

 

2

%

(5

)

-

(17

)

(3

)

(0

%)

 
Quarter Ended June 30
Xylem Inc.

2,336

2,301

35

 

2

%

(7

)

31

(29

)

30

 

1

%

Water Infrastructure

683

650

33

 

5

%

(4

)

2

(14

)

17

 

3

%

Applied Water

501

483

18

 

4

%

-

 

-

(5

)

13

 

3

%

Measurement and Control Solutions

508

540

(32

)

(6

%)

-

 

29

(4

)

(7

)

(1

%)

Water Solutions and Services

644

628

16

 

3

%

(3

)

-

(6

)

7

 

1

%

 
Quarter Ended March 31
Xylem Inc.

2,125

2,069

56

 

3

%

(5

)

5

(65

)

(9

)

(0

%)

Water Infrastructure

603

581

22

 

4

%

(3

)

5

(29

)

(5

)

(1

%)

Applied Water

448

435

13

 

3

%

-

 

-

(14

)

(1

)

(0

%)

Measurement and Control Solutions

508

490

18

 

4

%

-

 

-

(11

)

7

 

1

%

Water Solutions and Services

566

563

3

 

1

%

(2

)

-

(11

)

(10

)

(2

%)

Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
   
Q2 2026 Q2 2025
As Reported Adjustments Adjusted As Reported Adjustments Adjusted
Total Revenue

 

2,336

 

 

-

 

 

2,336

 

 

2,301

 

 

-

 

 

2,301

 

Operating Income

 

390

 

 

57

 

a

 

447

 

 

305

 

 

97

 

a

 

402

 

Operating Margin

 

16.7

%

 

19.1

%

 

13.3

%

 

17.5

%

Interest Expense

 

(7

)

 

-

 

 

(7

)

 

(9

)

 

-

 

 

(9

)

Other Non-Operating Income (Expense)

 

(3

)

 

7

 

b

 

4

 

 

3

 

 

-

 

b

 

3

 

Gain/(Loss) From Sale of Businesses

 

(16

)

 

16

 

c

 

-

 

 

-

 

 

-

 

c

 

-

 

Income before Taxes

 

364

 

 

80

 

 

444

 

 

299

 

 

97

 

 

396

 

Provision for Income Taxes

 

(103

)

 

2

 

d

 

(101

)

 

(75

)

 

(15

)

d

 

(90

)

Net Income

 

261

 

 

82

 

 

343

 

 

224

 

 

82

 

 

306

 

Net Loss Attributable to Non-controlling Interests

 

2

 

 

-

 

 

2

 

 

2

 

 

-

 

 

2

 

Net Income Attributable to Xylem

 

263

 

 

82

 

 

345

 

 

226

 

 

82

 

 

308

 

Diluted Shares

 

236.6

 

 

236.6

 

 

243.9

 

 

243.9

 

Diluted EPS

$

1.11

 

$

0.35

 

$

1.46

 

$

0.93

 

$

0.33

 

$

1.26

 

   
   
Q2 YTD 2026 Q2 YTD 2025
As Reported Adjustments Adjusted As Reported Adjustments Adjusted
Total Revenue

 

4,461

 

 

-

 

 

4,461

 

 

4,370

 

 

-

 

 

4,370

 

Operating Income

 

634

 

 

155

 

a

 

789

 

 

536

 

 

191

 

a

 

727

 

Operating Margin

 

14.2

%

 

17.7

%

 

12.3

%

 

16.6

%

Interest Expense

 

(11

)

 

-

 

 

(11

)

 

(17

)

 

-

 

 

(17

)

Other Non-Operating Income (Expense)

 

(3

)

 

12

 

b

 

9

 

 

7

 

 

-

 

b

 

7

 

Gain/(Loss) From Sale of Businesses

 

(12

)

 

12

 

c

 

-

 

 

(10

)

 

10

 

c

 

-

 

Income before Taxes

 

608

 

 

179

 

 

787

 

 

516

 

 

201

 

 

717

 

Provision for Income Taxes

 

(158

)

 

(18

)

d

 

(176

)

 

(125

)

 

(37

)

d

 

(162

)

Net Income

 

450

 

 

161

 

 

611

 

 

391

 

 

164

 

 

555

 

Net Loss Attributable to Non-controlling Interests

 

6

 

 

-

 

 

6

 

 

4

 

 

-

 

 

4

 

Net Income Attributable to Xylem

 

456

 

 

161

 

 

617

 

 

395

 

 

164

 

 

559

 

Diluted Shares

 

240.0

 

 

240.0

 

 

243.8

 

 

243.8

 

Diluted EPS

$

1.90

 

$

0.67

 

$

2.57

 

$

1.62

 

$

0.67

 

$

2.29

 

   

a

Quarter-to-date:

 

Restructuring & realignment costs: 2026 - $15 million; 2025 - $29 million

 

Special charges: 2026 - $6 million of acquisition, divestiture & integration costs, offset by $16 million of IEEPA tariff refunds ; 2025 - $9 million of acquisition, divestiture & integration costs and $4 million of intangible asset impairment charges

 

Purchase accounting intangible amortization: 2026 - $52 million; 2025 - $55 million

 

Year-to-date:

 

Restructuring & realignment costs: 2026 - $53 million and 2025 - $56 million

 

Special charges: 2026 - $11 million of acquisition, divestiture & integration costs, offset by $16 million of IEEPA tariff refunds; 2025 - $17 million of acquisition & integration related costs and $8 million of intangible asset impairment charges

 

Purchase accounting intangible amortization: 2026 - $107 million and 2025 - $110 million

b

Other special charges

 

c

Gain/(Loss) from sale of businesses as per income statement for all periods presented

d

Quarter-to-date: 2026 - Net tax impact on pre-tax adjustments (notes a, b and c) of $13 million, offset by $15 million of other tax special expense items; 2025 - Net tax impact on pre-tax adjustments (note a, b and c) of $20 million, offset by $5 million of other tax special expense items;

 

Year-to-date: 2026 - Net tax impact on pre-tax adjustments (notes a, b and c) of $34 million, offset by $16 million of other tax special expense items; 2025 - Net tax impact on pre-tax adjustments (note a, b and c) of $42 million, offset by other tax special expense items of $5 million;

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
   

2026

Q1 Q2 Q3 Q4 Total
   
Net Income attributable to Xylem

193

 

263

 

456

 

Net Income margin

9.1

%

11.3

%

10.2

%

Depreciation

65

 

65

 

130

 

Amortization

75

 

75

 

150

 

Interest Expense (Income), net

(4

)

2

 

(2

)

Income Tax Expense

55

 

103

 

158

 

EBITDA

384

 

508

 

892

 

Share-based Compensation

13

 

12

 

25

 

Restructuring & Realignment

38

 

13

 

51

 

Special Charges

10

 

(3

)

7

 

Loss/(Gain) from sale of businesses

(4

)

16

 

12

 

Loss attributable to non-controlling interests

(4

)

(2

)

(6

)

Adjusted EBITDA

437

 

544

 

981

 

Revenue

2,125

 

2,336

 

4,461

 

Adjusted EBITDA Margin

20.6

%

23.3

%

22.0

%

   

2025

Q1 Q2 Q3 Q4 Total
 
Net Income attributable to Xylem

169

 

226

 

227

 

335

 

957

 

Net Income margin

8.2

%

9.8

%

10.0

%

14.0

%

10.6

%

Depreciation

68

 

69

 

64

 

66

 

267

 

Amortization

77

 

76

 

78

 

77

 

308

 

Interest Expense (Income), net

-

 

3

 

-

 

(1

)

2

 

Income Tax Expense

50

 

75

 

71

 

35

 

231

 

EBITDA

364

 

449

 

440

 

512

 

1,765

 

Share-based Compensation

12

 

13

 

12

 

16

 

53

 

Restructuring & Realignment

27

 

29

 

30

 

45

 

131

 

Special Charges

12

 

13

 

9

 

2

 

36

 

Loss/(Gain) from sale of businesses

10

 

-

 

37

 

(16

)

31

 

Loss attributable to non-controlling interests

(2

)

(2

)

(1

)

(2

)

(7

)

Adjusted EBITDA

423

 

502

 

527

 

557

 

2,009

 

Revenue

2,069

 

2,301

 

2,268

 

2,397

 

9,035

 

Adjusted EBITDA Margin

20.4

%

21.8

%

23.2

%

23.2

%

22.2

%

 

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.79
-2.60 (-1.12%)
AAPL  338.08
+1.17 (0.35%)
AMD  451.42
-43.53 (-8.79%)
BAC  62.30
+0.16 (0.27%)
GOOG  327.73
+1.16 (0.35%)
META  591.45
-2.42 (-0.41%)
MSFT  395.35
+6.25 (1.61%)
NVDA  195.84
-0.67 (-0.34%)
ORCL  115.62
-4.28 (-3.57%)
TSLA  302.13
-7.09 (-2.29%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.